LTFS
TAK icon

Ladenburg Thalmann Financial Services’s Takeda Pharmaceutical TAK Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$766K Sell
38,825
-1,305
-3% -$25K ﹤0.01% 1481
2019
Q3 		$690K Sell
40,130
-582
-1% -$10.1K ﹤0.01% 1509
2019
Q2 		$716K Buy
40,712
+2,509
+7% +$45.7K 0.01% 1463
2019
Q1 		$779K Buy
38,203
+15,203
+66% +$306K 0.01% 1351
2018
Q4 		$384K Buy
+23,000
New +$388K ﹤0.01% 1738

Other funds holding TAK

GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
AC
Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Ladenburg Thalmann Financial Services's TAK Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Takeda Pharmaceutical (TAK) stake by 3.3% in Q4 2019, selling an estimated $25K and leaving 38,825 shares worth $766K. The position accounts for ﹤0.01% of the portfolio, ranked #1481.

Ladenburg Thalmann Financial Services first reported a position in TAK in Q4 2018 and has held it in 5 quarters since. The position peaked at $779K in Q1 2019. 339 funds tracked by Wall St. Rank hold TAK as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 38,825 shares of Takeda Pharmaceutical worth $766K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 1,305 Takeda Pharmaceutical shares in Q4 2019, an estimated $25K.
  • Takeda Pharmaceutical made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #1481 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 5 quarters since.
  • Ladenburg Thalmann Financial Services's Takeda Pharmaceutical position peaked at $779K in Q1 2019.
  • 339 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.